| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| accession | P13236 |
| express system | E.coli |
| product tag | none |
| purity | > 97% by SDS PAGE |
| molecular weight | Predicted Molecular Mass: 7.818 kDa Extinction Coefficient: 12, 570 M-1 cm-1 Actual Molecular Mass (Mass Spec): 7.818 kDa by ESI Mass Spec |
| available size | 100 µg, 1mg, 20 µg, 5 µg, 50 µg |
| endotoxin | <0.01 EU per 1μg of the protein by the LAL method |
| sequence | APMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSES WVQEYVYDLELN |
Macrophage inflammatory proteins 1-B (MIP-1B/CCL4) 6005
Price range: $61.00 through $2,189.00
Summary
- Expression: E.coli
- Amino Acid Range: 24-92
Macrophage inflammatory proteins 1-B (MIP-1B/CCL4) 6005
| antibody |
|---|
| Database link: human P13236 |
| Size and concentration 5, 20, 50, 100, 1000µg and lyophilized |
| Form Lyophilized |
| Storage Instructions Avoid repeated freeze-thaw cycles: • 12 months from date of receipt, -20 to -70 °C as supplied. • 1 month, 2 to 8 °C under sterile conditions after reconstitution. • 3 months, -20 to -70 °C under sterile conditions after reconstitution |
| Storage buffer Reconstitution: Spin sample prior to reconstitution. Recommended concentration of 100µg/mL in sterile water. Shipping: Room Temp |
| Purity > 97% by SDS PAGE and HPLC |
| target relevance |
|---|
| Homo sapiens CCL4 C-C motif chemokine 4 |
| Protein names C-C motif chemokine 4 |
| Alternative names G-26 T-lymphocyte-secreted protein, HC21, Lymphocyte activation gene 1 protein, MIP-1-beta(1-69), Macrophage inflammatory protein 1-beta, PAT 744, Protein H400, SIS-gamma, Small-inducible cytokine A4, T-cell activation protein 2 |
| Gene names CCL4 |
| Protein family Belongs to the intercrine beta (chemokine CC) family |
| Function Monokine with inflammatory and chemokinetic properties. Binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-beta induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-beta(3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T-cells. MIP-1-beta(3-69) is also a ligand for CCR1 and CCR2 isoform B |
| Subcellular location Secreted |
| Structure Homodimer and heterodimer of MIP-1-alpha(4-69) and MIP-1-beta(3-69) |
| Post-translational modification N-terminal processed form MIP-1-beta(3-69) is produced by proteolytic cleavage after secretion from peripheral blood lymphocytes |
| Keywords 3D-structure, Chemotaxis, Cytokine, Disulfide bond, Inflammatory response, Proteomics identification, Reference proteome, Secreted, Signal |
| Sequence MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQ PAVVFQTKRSKQVCADPSESWVQEYVYDLELN |
| UniProt accession: P13236 |
Data
![]() |
| Migration Assay: Cells expressing recombinant CCR5 were assayed for migration through a transwell filter at various concentrations of MIP-1b. Responses are expressed as the % of total input cells. |
FAQ & Publications
Frequently Asked Questions
What is the recommended storage condition and stability for the Macrophage Inflammatory Protein 1-B (MIP-1B/CCL4) product?
The lyophilized product should be stored at -20 to -70 °C and is stable for 12 months from the date of receipt. After reconstitution, it can be kept for 1 month at 2 to 8 °C under sterile conditions or for 3 months at -20 to -70 °C under sterile conditions. Avoid repeated freeze-thaw cycles to maintain protein integrity.
What is the source expression system and purity level of this recombinant MIP-1B/CCL4 protein?
This recombinant MIP-1B/CCL4 protein is expressed in Escherichia coli (E.coli) and has a purity greater than 97% as determined by SDS-PAGE and HPLC analyses.
What is the biological relevance of MIP-1B/CCL4 and its known interactions with chemokine receptors?
MIP-1B/CCL4 is a monokine with inflammatory and chemokinetic properties that binds primarily to the CCR5 receptor. It acts as a major HIV-suppressive factor produced by CD8+ T-cells and induces dose-dependent inhibition of HIV-1, HIV-2, and SIV strains. The processed form, MIP-1-beta(3-69), can down-modulate CCR5 surface expression and inhibit CCR5-mediated HIV-1 entry into T-cells, and it also acts as a ligand for CCR1 and CCR2 isoform B.
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Protocols
| relevant to this product |
|---|
| Migration assay |
Documents
| # | ||
|---|---|---|
| Please enter your product and batch number here. | ||
Only logged in customers who have purchased this product may leave a review.

















Reviews
There are no reviews yet.